The TRANSFORM-2 study found patients receiving Spravato were 70% more likely to achieve remission than those on a newly initiated oral antidepressant plus placebo
Spravato Treatment in Pearland, TX: FDA-Approved Relief for Treatment-Resistant Depression
Find the best Spravato treatment clinic serving Pearland, TX at Catalyst Health & Wellness — a trusted, REMS-certified Houston provider of the only FDA-approved nasal spray for treatment-resistant depression. Led by Dr. Ho, board-certified anesthesiologist and former pediatrician. Three Houston locations open Monday–Sunday, 5am–9pm.
Reclaim Yourself with Spravato Treatment Pearland
Pearland has become one of the fastest-growing communities in the entire Houston region — and for good reason. Excellent schools, thoughtfully developed neighborhoods, a genuine sense of community, and the kind of quality municipal services that attract young families and established residents alike. But growth and amenities can’t shield a community from treatment-resistant depression, and the isolation that condition creates doesn’t care how appealing the neighborhood looks from the outside.
If multiple antidepressants have come and gone without delivering the relief you needed, you’re not facing a personal failing. You’re facing a neurobiological mismatch — and that mismatch has a clinically proven solution. At Catalyst Health & Wellness, we serve Pearland residents — along with patients from Shadow Creek Ranch, Manvel, Friendswood, and the greater south Houston area — as a fully REMS-certified Spravato provider. Spravato (esketamine) is the only FDA-approved nasal spray built specifically for treatment-resistant depression, and Cleveland Clinic researchers describe it as positioned to “play a very important role in the short-term management of treatment-resistant depression because it can provide rapid relief.” With Dr. Ho’s specialized expertise, full-service insurance support, and a schedule designed around Pearland patients’ real lives, Catalyst makes that rapid relief accessible.
What is Spravato Therapy?
Spravato (esketamine) earned FDA breakthrough therapy designation before receiving full approval in 2019. That designation marks only treatments showing early evidence of substantial benefit over existing options for serious conditions — and Spravato earned it by demonstrating something the psychiatric world hadn’t seen in decades: an antidepressant that worked through an entirely new neurological mechanism and produced results within hours rather than weeks. In 2020, the FDA expanded that approval to include adults with major depressive disorder experiencing active suicidal ideation or behaviors.
Research consistently shows powerful results:
What Our Patients Say
Take the First Step Toward Healing
Book Appointment
Conditions We Treat with Spravato Therapy in Pearland
Spravato carries FDA approval for two specific, well-defined clinical indications — every qualifying Pearland patient receives a treatment with a thoroughly documented safety and efficacy record. At Catalyst Health & Wellness, we offer Spravato for:
Your Spravato Therapy Journey at Catalyst Health & Wellness
Every phase of the Spravato process at Catalyst has been designed to reduce uncertainty, minimize administrative burden, and make treatment genuinely achievable for Pearland patients with full lives. Here's what to expect.
Step 1: Free Phone Consultation
Your first conversation with our team costs nothing and commits you to nothing. A clinical team member will walk through your depression history, medication background, and what daily life looks like today. You’ll receive an honest, clear-eyed assessment of whether Spravato makes sense for your situation — including an honest answer if it doesn’t.
Step 2: Insurance Verification & Prior Authorization
Spravato is often covered by insurance for qualifying patients, but prior authorization is nearly always required. Our team handles it entirely: verifying your benefits, building the documentation, submitting the prior authorization, and following through with your insurer until it’s approved. You make the decision; we run the process.
Step 3: Before Your First Visit
Before your appointment, we’ll cover everything: dietary guidelines, what to bring, transportation logistics, and timing notes for your current medications. Every detail will be addressed before your first session begins.
Step 4: Day of Treatment
Plan for approximately two to two-and-a-half hours per visit. You’ll need a designated driver or pre-arranged rideshare — driving on treatment days is not permitted. Come comfortable and ready to rest. That’s the full extent of preparation required.
Step 5: Your Treatment Session
You’ll settle into a private, purpose-built treatment room — reclinable chair, soft adjustable lighting, warm blankets, noise-cancelling headphones available. Spravato is self-administered as a nasal spray under direct clinical supervision. Dr. Ho’s team monitors your vital signs, blood pressure, and overall response throughout. Temporary effects — mild dissociation, light-headedness — are expected and typically resolve within the two-hour monitoring window.
Step 6: Recovery & Aftercare
After monitoring ends, you’ll leave with your driver. Driving should wait until the morning following a full night’s sleep. Our team follows up between sessions to track your response and address anything that needs adjusting before your next visit.
Step 7: Treatment Schedule & Maintenance
The protocol begins with twice-weekly sessions during weeks one through four, steps to once weekly in weeks five through eight, then transitions to individualized maintenance — weekly, every two weeks, or monthly — based on how you’re actually responding. Your progress, not a calendar, shapes the schedule.
The Science Behind Spravato for Treatment-Resistant Depression
Spravato’s FDA approval rests on a rigorous clinical evidence base anchored by two pivotal phase 3 randomized controlled trials and supported by nearly five years of real-world safety data.
The TRANSFORM-2 study, published in the American Journal of Psychiatry, enrolled patients with confirmed treatment-resistant depression in a double-blind comparison of flexibly-dosed Spravato plus a newly initiated oral antidepressant versus antidepressant plus placebo. Patients on Spravato were 70% more likely to achieve remission. Statistically significant symptom improvement was measurable within 24 hours of the first dose — before the oral antidepressant in either arm could have reached therapeutic blood levels. Cleveland Clinic researchers have described esketamine’s advantage as operating precisely through this speed: “both drugs act rapidly, within several hours of administration, and this is their main advantage when compared with the 4- to 6-week onset of action for traditional antidepressants.”
The SUSTAIN-1 trial, published in JAMA Psychiatry, established that those gains sustain. Patients who had achieved stable remission or response were randomized to continue Spravato or transition to placebo. Those who continued Spravato had significantly longer time to relapse — a hazard ratio of 0.49 (p=0.003). This confirmed that maintenance treatment is a meaningful clinical commitment with measurable long-term benefit, not a formality.
Key research findings:
- Spravato triggers synaptogenesis and neuroplasticity in mood-regulating brain regions within hours of the first dose — active neural repair, not chemical adjustment
- The ASPIRE I and II trials confirmed statistically significant depressive symptom reduction within 24 hours in patients with MDD and active suicidal ideation — addressing a population for whom no prior rapid pharmacological option existed
- Esketamine is the only pharmacological agent with glutamatergic neuromodulatory properties approved by both the FDA and European Medicines Agency for treatment-resistant depression — a global consensus reflecting the quality and reproducibility of its evidence base
- January 2025 FDA approval of esketamine as a monotherapy option for TRD marks the newest chapter in its expanding clinical evidence base
Why Choose Catalyst Health & Wellness for Spravato Treatment in Pearland
01
REMS-Certified Provider
The FDA requires all Spravato treatments to occur in a healthcare setting certified under its Risk Evaluation and Mitigation Strategy (REMS) program. Catalyst Health & Wellness holds full REMS certification across all three Houston locations. Every session meets every federal safety requirement — without exception, without shortcuts.
02
Led by Dr. Ho – Expert Medical Care
Dr. Ho brings precisely what Spravato treatment demands. His board certification in anesthesiology means deep expertise in esketamine pharmacology, clinical dosing, and the physician-level monitoring that safe administration requires. His background as a former pediatrician shapes a care culture that’s patient-first, unhurried, and genuinely attentive to how treatment feels from the patient’s perspective — not just how it performs on paper. Pearland patients deserve that level of physician-led care and human attentiveness.
03
Insurance Navigation Support
Spravato is distinctive because major commercial insurance plans and Medicare frequently cover it for qualifying patients. Prior authorization is nearly always required, and the documentation process is one more burden patients managing depression shouldn’t have to carry alone. Our team handles it entirely: benefit verification, prior auth submission, insurer communication, and appeals when needed. We’ve done this across dozens of different insurance plans. Your energy belongs to your health.
04
Whole-Person Approach
From the first call, we engage with you as a complete person — your treatment history, your current life, your goals, and what you want back. Treatment plans are built around that full picture and updated as your response evolves. What this means for you:
- Plans shaped by your specific history and present situation
- Ongoing adjustments based on real response data, not a standardized protocol
- Coordination with your existing psychiatrist or prescribing physician
- Long-term engagement that extends well beyond the initial treatment series
05
Extended Hours & Flexible Scheduling
Each Spravato session requires two or more hours in clinic. For Pearland residents managing professional careers, family obligations, and long commutes into Houston, fitting a standard clinic window into the schedule can be genuinely impossible. Our 5am to 9pm hours, seven days a week at all three Houston locations, were designed to solve that problem. Pre-dawn appointments, evening sessions, Saturday or Sunday — all available. If scheduling has been the reason you’ve delayed treatment you know you need, that barrier is removed.
06
Comprehensive Treatment Options
Spravato is a powerful tool, but it’s not the only one. When your clinical picture benefits from a multi-modal approach, Catalyst offers complementary evidence-based treatments under the same roof:
Ketamine Therapy
Broader applications including anxiety, PTSD, chronic pain, OCD, and bipolar depression
TMS Therapy
Non-invasive magnetic brain stimulation for depression and OCD
Stellate Ganglion Block
Targeted nerve block treatment for PTSD and anxiety
Our goal is to find the right combination of treatments for your unique situation — not to fit you into a one-size-fits-all protocol.
07
Safe, Comfortable Environment
Our treatment rooms were built for the Spravato experience, not repurposed from other clinical uses. Each is private, quiet, and purpose-designed: reclinable chairs, soft adjustable lighting, warm blankets, noise-cancelling headphones. Dr. Ho’s clinical team is present and monitoring throughout every session. You’re observed, supported, and never alone during treatment.
Getting Started with Spravato Treatment in Pearland
Pearland’s rapid growth has been driven by people who recognize quality and invest in it. If treatment-resistant depression has been the one area of your life where that standard hasn’t yet been met — where the options you’ve tried have fallen short — Spravato offers a clinically proven, FDA-approved path forward that’s accessible right now, from a clinic your community can reach.
Call us at 800-772-1242 for your free, no-obligation phone consultation. We’ll talk through your history honestly, answer every question, and give you a clear picture of whether Spravato is the right fit. No charge, no pressure, complete confidentiality.
Three Houston locations serve Pearland patients, and our 5am to 9pm hours every day of the week mean treatment works around your life rather than demanding that your life work around treatment. Dr. Ho and the entire Catalyst team are ready when you are.
Monday-Sunday, 6am-9pm
Free consultation
Insurance assistance
Three Houston locations
REMS-certified provider
Commonly Asked Questions
Get Help NowHow quickly does Spravato therapy work?
Many patients notice improvements within hours or days of their first treatment. The TRANSFORM-2 study showed significant improvement compared to placebo within 24 hours. This rapid action is one of Spravato’s most remarkable qualities, especially compared to traditional antidepressants that can take 4 to 8 weeks to work.
Is Spravato therapy safe?
Yes, when administered by trained medical professionals in a REMS-certified setting. Spravato underwent extensive clinical trials before FDA approval. Common side effects like dissociation, dizziness, and temporary blood pressure increases typically resolve within 1-2 hours. We monitor your vital signs throughout treatment to ensure your safety.
How many treatments will I need?
During the first month, you’ll receive Spravato twice weekly. In the second month, treatment typically decreases to once weekly. After that, most patients continue with maintenance treatments once weekly or every two weeks. The exact frequency depends on your individual response. We’ll work with you to find the schedule that keeps you feeling your best.
What does Spravato treatment feel like?
Experiences vary from person to person. Many patients describe feeling relaxed, calm, or somewhat disconnected from their surroundings. Some people experience mild visual or sensory changes. These effects are temporary and typically resolve within 1-2 hours after treatment ends. Most patients find the experience manageable and therapeutic.
Can I drive after a Spravato treatment?
No, you cannot drive yourself home after Spravato treatment, and you should not drive until the next day after a restful night’s sleep. You’ll need to arrange transportation both to and from your appointment. By the time you leave our facility after the 2-hour observation period, you’ll feel much clearer, but driving remains unsafe until the following day.
Will my insurance cover Spravato?
Many insurance plans cover Spravato for qualifying patients since it’s FDA-approved for treatment-resistant depression. Coverage varies by plan and typically requires prior authorization. Our team handles the insurance process for you, including benefits verification and prior authorization submissions.
Can I continue my current medications?
Spravato is always used alongside an oral antidepressant, so you’ll continue taking your prescribed antidepressant medication. We’ll coordinate with your prescribing physician to ensure your overall treatment plan is optimized. Some medications may require adjustment before starting Spravato, which we’ll discuss during your consultation.
Do I need a referral from my doctor?
No, you don’t need a referral to begin Spravato therapy at Catalyst Health & Wellness. However, coordination with your current prescribing physician is important since Spravato must be used alongside an oral antidepressant. We encourage communication between all members of your healthcare team.
Our Locations
Blog & insight
Insights on Healing, Growth, and Mental Wellness
June 13, 2026
FAQ: Common Questions About Ketamine Treatment Answered
If you've been researching ketamine therapy in Houston, chances are you've come across a lot of conflicting information. One article calls it a miracle cure. Another paints it as a risky party drug. Somewhere in between sits the truth, and you deserve straightforward answers before making any decision about your mental health or chronic pain…
June 10, 2026
Can Ketamine Therapy Help with Both Depression and Anxiety?
If you've spent years battling depression only to find anxiety creeping in alongside it (or vice versa), you're not imagining the connection. These two conditions show up together far more often than people realize, and the overlap can make recovery feel like trying to untangle a knot that keeps tightening. Traditional antidepressants and anti-anxiety medications…
June 7, 2026
Neuropathic Pain and Ketamine: Relief When Nerve Pain Won’t Quit
If you live with neuropathic pain, you already know it doesn't behave like ordinary pain. It burns when nothing touched you. It shocks down your leg while you're sitting still. It turns the brush of a bedsheet into something sharp. And the medications your doctor prescribed, the gabapentin, the duloxetine, maybe even opioids, take the…
Make an Appointment
Our mission is to empower individuals to overcome life’s challenges through professional psychological support.